|
It was reported that the patient underwent an ion lung biopsy procedure and developed a pneumothorax which required chest tube placement and hospitalization.The target nodule measured 12 mm and was located in the right upper lobe, 3 mm from the pleural surface.The initial pneumothorax was not considered severe, and the physician elected to continue the procedure.However, a follow-up chest x-ray demonstrated an increase in pneumothorax size, necessitating chest tube placement for resolution.The physician did not attribute the pneumothorax to the ion system, noting it likely would have occurred via an alternative modality.The procedure had been classified as high risk preoperatively, and the pneumothorax was attributed to the patient's advanced age and significant fibrotic lung disease.No malfunction or device-related issues were identified with the ion system, instruments, or accessories.
|
|
An investigation was completed to determine the cause of this adverse event.There is no indication that the customer reported complication of pneumothorax was related to a product issue.There was no allegation that a malfunction of an ion system, instrument, or accessory occurred during the procedure.Blank mdr fields:
the missing patient information in sections a and b was either unknown, unavailable, not provided, or not applicable.The expiration date for section d4 is not applicable.Field d6 is blank because the product is not implantable.Information for the blank fields in section e1 is not available.Field e4 is blank because it is unknown if the initial reporter submitted a report to the fda.Fields g5 and g7 are not applicable.Field h10 is blank as there are no related report numbers.
|